FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Valsartan Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Teva Pharmaceuticals (New 08/03/2018)

Company Contact Information:

Presentation Posting Date Related Information
Valsartan Tablets, USP 40mg, 90 count, (NDC 0591-2167-19) 08/03/2018 This was a business-related decision to discontinue manufacturing these products.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English